Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its lead asset, nizubaglustat, will ...
AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...
Five presentations will showcase nizubaglustat's therapeutic potential in Lysosomal Storage Disorders. Nizubaglustat is currently being tested in two global Phase 3 studies for Niemann-Pick ...
Scientific posters are often the first release of clinical data to the medical community. REVEAL is an end-to-end tailored platform that revolutionises the way scientific posters are created, enhanced ...
PALI-2108 Abstracts Highlight Gut-Targeted PDE4B Inhibition and Translational Phase 1a Findings in Ulcerative ColitisCarlsbad, CA, ...
Scientific posters will be displayed in the Experience Hub on Thursday, July 16 with the Welcome Reception. Presenters are expected to be present with their poster to discuss their research and ...
One researcher turned her scientific findings into character dialogue to simplify complex concepts. After seeing how ...
The symposium brings together scientists and clinicians whose specialties span from bench to bedside, with the shared goal of ...
The educator spoke about how he’s spreading his love of science into communities that might not have access to robust STEM ...
The Entrepreneurship Cell (E-Cell) of NES Ratnam College of Arts, Science & Commerce (Autonomous), Bhandup, is set to ...
The 14th edition of the International Conference and Exhibition on Pharmacy and Medicine (ICPM) opened on Wednesday at ...
The event attracted more than 150 local, regional, and global companies and institutions specializing in healthcare services, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback